The Era of 'Involution' in Pilot-Scale Platforms Is Approaching: After the Hardware Arms Race, Operational Capability May Become the Ultimate Challenge

Click the image to view event details

Recently, the national level has successively issued4The document supports the construction of pilot-scale platforms for bio-manufacturing.

• 11Month11Recently, the Ministry of Industry and Information Technology issued the “Notice on Further Accelerating the Systematic Layout and High-Level Development of Pilot-Scale Testing Platforms in the Manufacturing Sector”;

• 11Month10On the morning of [date], the Ministry of Industry and Information Technology (MIIT) website published the “List of Pilot-Scale Capability Building Platforms for Biomanufacturing (First Batch),” which includes43Home Enterprise/Institution;

• 11Month4Recently, the Ministry of Industry and Information Technology released a public notice listing the shortlisted entities for the “Unveiling the List” initiative on innovative tasks related to high-performance bioreactors;

• 11Month7Recently, the State Council released the "Implementation Opinions on Accelerating Scenario Cultivation and Opening to Promote Large-Scale Application of New Scenarios," encouraging the cultivation of application scenarios for producer services such as pilot testing and validation.

At the regional level, according toVCBeatIncomplete Overview,Beijing, Shanghai, Guangdong Province, Chongqing, Sichuan Province, Henan Province, Guizhou Province, Fujian Province, Inner Mongolia, Shandong Province, Jiangsu Province, Hubei Province, and other regions have all introduced relevant policies or initiatives to explicitly support the development of pilot-scale production platforms.

For example, Guangdong Province once announced that it would2.2Project for the Construction of a Synthetic Biology Manufacturing Pilot-Scale Platform with an Investment of 100 Million Yuan; Total Investment in the Changde Economic and Technological Development Zone’s Synthetic Biology Manufacturing Pilot-Scale Transformation Platform1.69100 million yuan, covering an area of46mu; Phase I of the Zhangzhou Chemical and Biopharmaceutical Science and Technology Innovation Pilot-Scale Base,Total investment: approximately9.68100 million yuan.

Amid the surge in the construction of pilot-scale platforms for biomanufacturing, Dr. Fang, a professional in the field of biomanufacturing, analyzes that this sector may be on the verge of entering its “Year One of Involution.” After all,2025Before the year has even ended, the excellent pilot-scale capability development platforms selected by the national team have already43The intensive rollout of policies signifies a sharp acceleration in industry competition.

Therefore, future competition will not be about “whether or not one has a pilot-scale production platform,” but rather—can the pilot-scale platform truly enable products to reach the market? Where will the cash flow needed to sustain operations come from? Will it become a “fixed-asset black hole” on corporate balance sheets?

This wave of pilot-scale platform development is by no means a case of “first to build, first to win.” Rather, it is about “those who build correctly are the ones who survive.” Dr. Fang has learned that mainstream equipment manufacturers have already secured numerous orders from platform developers. However, the more expensive, complex, and large-scale the equipment becomes, the more likely it seems to result in a:“Mega-Labs That Cannot Sustain Operations”

Therefore, operational and service capabilities may become one of the key factors for the survival and competitiveness of pilot-scale platforms in the future, with talent being at the core of these operational services.

VCBeat has learned through research interviews that the current domestic pilot-scale service workforce is not sufficiently robust, and that pilot-scale platforms must be implemented within each specialized sector to address specific challenges.Therefore, it is not only necessary to have sound hardware facilities, but also essential to build a team of specialized professionals within the vertical sector.

It is understood that China’s specialized talent system for pilot-scale testing remains incomplete. The development of pilot-scale testing platforms encompasses multifaceted innovation demands in technology, management, market, and finance. Relying solely on the participation of scientific researchers is far from sufficient; there is also a need for professionals from diverse fields such as process engineering, trial production, and quality control. To some extent, the shortage of specialized personnel for pilot-scale testing has constrained the smooth progress of these activities.

Specifically, in the current process of building pilot-scale platforms,There is a severe shortage of fermentation engineering technicians, and many synthetic biology researchers are simultaneously undertaking the development of fermentation processes.However, they struggle to grasp the complexity of fermentation processes, often approaching them with a deterministic mindset akin to cell engineering, under the assumption that “inoculating cells into a fermenter should yield the expected results.” They find it difficult to appreciate the high degree of uncertainty inherent in fermentation, as the process is constantly subject to various uncontrollable factors, resulting in perpetual data fluctuations.

What the industry urgently needs now is composite talent such as “Senior Fermentation Engineers,” who can both understand scientists’ research and address the practical needs of industrial workers.; Such talent must be proficient in both intracellular biological processes and extracellular engineering control technologies, capable of integrating knowledge from both fields and providing professional interpretations based on their own knowledge systems and experience.

Synthetic biology researchers typically focus on molecular-level changes within cells, adopting a static and deterministic mindset. They primarily consider introducing genes into cells to construct metabolic pathways or networks, envisioning that the cells will express and function according to predefined trajectories.

However, cellular behavior is in fact profoundly influenced by external environmental conditions, necessitating the involvement of professionals with an engineering background to investigate and address the impact of these conditions on cell phenotypes, as well as intracellular and extracellular interactions.

In addition to talent issues, pilot-scale platforms should also adopt a market-oriented approach to break the deadlock of being “well-received in principle but poorly adopted in practice.”

It is understood that, for a long time, the pilot-scale testing phase has been regarded as “public-interest” supporting infrastructure due to its high investment requirements, long cycles, and significant risks, resulting in insufficient willingness among enterprises to participate. Therefore, it is necessary to “adhere to market dominance and demand-driven guidance” to infuse pilot-scale platforms with market-oriented characteristics.

Taking a national-level laboratory as an example, its cosmetics pilot-scale platform was established through “technology equity investment”+“Service Fee” model, which provides process validation services to startups while also earning revenue shares through product incubation, achieving annual revenues exceeding ten million yuan.“The self-sustaining” mechanism not only alleviates the fiscal burden but also compels platforms to improve service quality.

VCBeat has learned that the core conceptual shift in the marketization of pilot-scale platforms lies inIt should not view itself as an isolated research facility, but rather position itself as a market-oriented solutions provider.

Therefore, it is necessary to proactively explore the front lines of the industry rather than passively wait. For instance, a market team can be established to conduct in-depth needs assessments at enterprises—particularly startups and industry leaders—to understand their real pain points in process scale-up, cost control, and regulatory compliance.

Furthermore, by focusing on niche sectors. Given that pilot-scale platforms cannot serve all fields, it is essential to concentrate on a few high-growth, high-value niche markets—such as biopharmaceuticals, medical aesthetics and health, bio-based materials, and food technology—based on their own strengths and local industrial planning, so as to achieve in-depth and thorough development.

Therefore, judging from the aforementioned trends, the development of pilot-scale platforms for biomanufacturing in China has officially transitioned from a “build-as-needed” approach1.0phase, stepping into an era of “intensive and meticulous cultivation”2.0Era.

Enter2.0In this era, the efficient construction and operational management of pilot-scale platforms for biomanufacturing are fraught with challenges, requiring a holistic approach that integrates multiple dimensions—including technology, equipment, talent, policy, and sustainable development—thus demanding interdisciplinary knowledge and practical experience.

As pilot-scale platforms across various regions have been successively completed,2.0 The Core Proposition of the Era Has Become Clear: How to make these high-investment, high-standard platforms truly“Live”How can we get it up and running to achieve efficient operations and maximize value? Platform operational strategies, talent allocation, process management, risk control, and sustainable development capabilities will all be key determinants of success or failure.

To Crack the Pilot-Scale Platform2.0After the successful completion of four sessions of the training program jointly launched by Dr. Fang and VCBeat to address operational management challenges in the current era,Phase 5 of the training program shifts its focus to the operation and management following platform development.

Practical experts from benchmark institutions such as the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences; Bloomage Biotech; and Shandong University will provide you withIn-Depth Operations and Practices Following the Establishment of a Dismantling Platform。

Keeping Pace with Industry Development: Time Waits for No One. Training on the Concepts and Plans for the Construction of the Fifth Phase of the Biomanufacturing Pilot-Scale Platform,11Month26-27Sun, we sincerely invite you to join usJiangsu·Changshu。

Click the image to view event details

30 secondsComplete a short survey

Add WeChat to claimResearch Report on the Biomanufacturing IndustryGift Pack